Neuro-Oncology: The Podcast
DuraciĆ³n total:
16 h 17 min
Immunotherapy drives mesenchymal shift in GBM
Neuro-Oncology: The Podcast
24:18
Long-term outcomes of pediatric patients with optic pathway glioma
Neuro-Oncology: The Podcast
15:11
NF1 mutation and neuronal hyperexcitability
Neuro-Oncology: The Podcast
22:56
Postoperative cerebellar mutism
Neuro-Oncology: The Podcast
32:20
Cell cycle checkpoints and alkylating agents
Neuro-Oncology: The Podcast
18:20
Liquid biopsy in CNS lymphoma
Neuro-Oncology: The Podcast
21:29
Immunotherapy for glioblastoma, lessons learned
Neuro-Oncology: The Podcast
29:55
TERTp mutation clonality in glioma
Neuro-Oncology: The Podcast
33:22
Liquid biopsy in H3K27M glioma
Neuro-Oncology: The Podcast
27:20
Glioma genetic profiles and electrophysiologic hyperexcitability
Neuro-Oncology: The Podcast
22:29
Epidemiology of glioma in Belgium
Neuro-Oncology: The Podcast
13:17
The Biology of H3K27M Mutant Gliomas
Neuro-Oncology: The Podcast
14:37
3D tumor volume assessment in PCNSL
Neuro-Oncology: The Podcast
27:36
Brain-tumor related epilepsy; a SNO consensus review
Neuro-Oncology: The Podcast
26:55
Vorasidenib and grading of IDH mutant astrocytoma
Neuro-Oncology: The Podcast
24:11
Insulin feedback and PI3K inhibition in GBM
Neuro-Oncology: The Podcast
25:07
SOX10 indel mutations in schwannomas
Neuro-Oncology: The Podcast
28:50
Dendritic cell vaccines in gliomas
Neuro-Oncology: The Podcast
17:22
Intrathecal trastuzumab for leptomeningeal metastases
Neuro-Oncology: The Podcast
21:05
Short term topiramate for radiation induced cytotoxic edema
Neuro-Oncology: The Podcast
14:10
Venous thromboembolism in gliomas
Neuro-Oncology: The Podcast
28:25
RANO resect
Neuro-Oncology: The Podcast
20:08
Methylation profiling of adult ependymoma
Neuro-Oncology: The Podcast
18:18
Pseudoprogression in IDH-mutant high-grade gliomas
Neuro-Oncology: The Podcast
25:32
Changes in survival outcomes in melanoma patients with brain metastases
Neuro-Oncology: The Podcast
19:35
Radiation therapy and structural brain changes
Neuro-Oncology: The Podcast
23:32
Objective response rate targets for recurrent glioblastoma clinical trials
Neuro-Oncology: The Podcast
31:36
Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era
Neuro-Oncology: The Podcast
12:33
Palliative care in neuro-oncology
Neuro-Oncology: The Podcast
30:56
Nivolumab in MGMT methylated GBM
Neuro-Oncology: The Podcast
20:04
IDH mutant gliomas; SNO consensus Review
Neuro-Oncology: The Podcast
51:48
DNA methylation subclass and extent of GBM resection
Neuro-Oncology: The Podcast
25:52
Pre-operative [11C]methionine PET for low-grade glioma
Neuro-Oncology: The Podcast
15:20
The role of T lymphocytes in the glioma pathobiology
Neuro-Oncology: The Podcast
16:35
CDKN2A homozygous deletion in IDH mutant astrocytoma
Neuro-Oncology: The Podcast
38:46
EGFR: the lazarus target in glioblastom
Neuro-Oncology: The Podcast
37:42
Brain metastases; a SNO consensus review: Part 2
Neuro-Oncology: The Podcast
33:14
Brain metastases; a SNO consensus review: Part 1
Neuro-Oncology: The Podcast
27:15
Pediatric IDH mutant gliomas
Neuro-Oncology: The Podcast
19:04
Low-risk meningioma: Outcomes from NRG 0539
Neuro-Oncology: The Podcast
20:37